A Phase 3,2-Part,Randomized,Double-Blind,Placebo-Controlled Study(Part 1)and Open-Label Extension(Part 2)to Evaluate the Efficacy,Safety,Pharmacokinetics,and Pharmacodynamics of Omaveloxolone(BIIB141)in Participants With Friedreich’s Ataxia Aged 2 to < 16
2026-09-14
عنوان الدراسة
A Phase 3,2-Part,Randomized,Double-Blind,Placebo-Controlled Study(Part 1)and Open-Label Extension(Part 2)to Evaluate the Efficacy,Safety,Pharmacokinetics,and Pharmacodynamics of Omaveloxolone(BIIB141)in Participants With Friedreich’s Ataxia Aged 2 to < 16
داعم الدراسة
Biogen Idec Research Limited
دواء الدراسة
Omaveloxolone (BIIB141)
رقم بروتوكول الدراسة
296FA301
حالة الدراسة
Ongoing
موقع الدراسة
1.King Faisal Specialist Hospital and Researech Center - Riyadh
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.